GlucoTrack, Inc.SEC Filings
|
|
All SEC filings by GlucoTrack, Inc. (GCTK) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 14, 2026 | |
| ARS | Annual report to shareholders | Jul 17, 2026 | ||
| 10-Q | Quarterly report | View Diff | May 14, 2026 | |
| 10-K | Annual report | View Diff | Mar 30, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 13, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 14, 2025 | |
| 10-Q | Quarterly report | View Diff | May 14, 2025 | |
| ARS | Annual report to shareholders | Apr 28, 2025 | ||
| 10-K | Annual report | View Diff | Mar 31, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 14, 2024 |
Events
| 8-K | Current report | Sep 9, 2026 | ||
| 8-K | Current report | Aug 28, 2026 | ||
| 8-K/A | Independent Accountant ’s Review Report | Aug 28, 2026 | ||
| 8-K | Glucotrack, Inc. Announces Reverse Stock Split | Aug 27, 2026 | ||
| 8-K | Current report | Aug 19, 2026 | ||
| 8-K | Current report | Aug 10, 2026 | ||
| 8-K | Glucotrack Announces $5.5 Million Financing | Aug 5, 2026 | ||
| 8-K | Advances Lt-100 Development Strategy Toward Single-Injection Administration | Jul 30, 2026 | ||
| 8-K/A | Current report | Jul 29, 2026 | ||
| 8-K | Current report | Jul 27, 2026 |
Registrations and Prospectuses
| 425 | Business combination disclosure | Aug 28, 2026 | ||
| 425 | Business combination disclosure | Jul 15, 2026 | ||
| 425 | Business combination disclosure | Jul 15, 2026 | ||
| POS AM | Prospectus update (post-effective amendment) | Apr 29, 2026 | ||
| 424B3 | Prospectus supplement | Jan 27, 2026 | ||
| S-3 | Shelf registration | View Diff | Jan 13, 2026 | |
| 424B3 | Prospectus supplement | Oct 30, 2025 | ||
| S-1/A | IPO registration | View Diff | Oct 8, 2025 | |
| S-1 | IPO registration | View Diff | Sep 29, 2025 | |
| S-8 | Registration of securities for employees | Sep 5, 2025 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Aug 21, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Aug 10, 2026 | |
| PRE 14A | Preliminary proxy | View Diff | Jul 31, 2026 | |
| DEF 14A | Definitive proxy | View Diff | Jul 17, 2026 | |
| PRE 14A | Preliminary proxy | View Diff | Jun 17, 2026 | |
| DEF 14A | Definitive proxy | View Diff | Feb 9, 2026 | |
| PRE 14A | Preliminary proxy | View Diff | Jan 29, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Nov 7, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | Nov 3, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | Oct 31, 2025 |
Other
| EFFECT | Notice of effectiveness | May 1, 2026 | ||
| EFFECT | Notice of effectiveness | Jan 28, 2026 | ||
| UPLOAD | Letter from SEC | Jan 27, 2026 | ||
| CORRESP | Correspondence with SEC | Jan 23, 2026 | ||
| EFFECT | Notice of effectiveness | Nov 13, 2024 | ||
| CORRESP | Correspondence with SEC | Nov 12, 2024 | ||
| CORRESP | Correspondence with SEC | Nov 12, 2024 | ||
| EFFECT | Notice of effectiveness | Oct 4, 2024 | ||
| CORRESP | Correspondence with SEC | Oct 1, 2024 | ||
| UPLOAD | Letter from SEC | Sep 27, 2024 |
Ownership
| SC 13G | White Lion Capital Llc Acquires Stake in Glucotrack, Inc. | Sep 2, 2026 | ||
| SC 13G/A | Beneficial ownership report | May 15, 2026 | ||
| SC 13G | Glucotrack, Inc. | Feb 17, 2026 | ||
| SC 13G | Glucotrack, Inc. | Feb 17, 2026 | ||
| 3 | Brendel Victoria Carr | Oct 7, 2025 | ||
| 4 | Andrew K Balo | Oct 7, 2025 | ||
| 4 | Luis Malave | Oct 7, 2025 | ||
| 4 | Erin Catherine Carter | Oct 7, 2025 | ||
| 4 | Paul Goode | Oct 7, 2025 | ||
| 4 | John A. Ballantyne Revocable Living Trust Dated 08/01/2017 | Mar 31, 2025 |